Charles Schwab Investment Management Inc Kymera Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

$527 Billion
Q4 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 387,187 shares of KYMR stock, worth $14.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

387,187

Previous 366,841 5.55%

Holding current value

$14.2 Million

Previous $17.4 Million 10.29%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	BUY	$39.06 - $51.84 $794,714 - $1.05 Million	20,346 Added 5.55%	387,187 $15.6 Million
Q3 2024 Nov 12, 2024	SELL	$30.16 - $52.4 $249,121 - $432,824	-8,260 Reduced 2.2%	366,841 $17.4 Million
Q2 2024 Aug 12, 2024	BUY	$29.85 - $39.42 $626,700 - $827,622	20,995 Added 5.93%	375,101 $11.2 Million
Q1 2024 May 08, 2024	BUY	$22.9 - $43.57 $1.09 Million - $2.07 Million	47,414 Added 15.46%	354,106 $14.2 Million
Q4 2023 Feb 06, 2024	BUY	$10.97 - $26.84 $54,312 - $132,884	4,951 Added 1.64%	306,692 $7.81 Million
Q3 2023 Nov 08, 2023	BUY	$13.9 - $23.88 $8,882 - $15,259	639 Added 0.21%	301,741 $4.19 Million
Q2 2023 Aug 09, 2023	BUY	$22.4 - $34.92 $58,351 - $90,966	2,605 Added 0.87%	301,102 $6.92 Million
Q1 2023 May 11, 2023	BUY	$24.84 - $38.75 $14,630 - $22,823	589 Added 0.2%	298,497 $8.84 Million
Q4 2022 Feb 13, 2023	BUY	$19.57 - $30.92 $378,640 - $598,240	19,348 Added 6.95%	297,908 $7.44 Million
Q3 2022 Nov 14, 2022	BUY	$20.91 - $34.27 $460,396 - $754,556	22,018 Added 8.58%	278,560 $6.07 Million
Q2 2022 Aug 15, 2022	BUY	$14.13 - $42.55 $17,874 - $53,825	1,265 Added 0.5%	256,542 $5.05 Million
Q1 2022 May 13, 2022	BUY	$35.3 - $64.68 $238,027 - $436,137	6,743 Added 2.71%	255,277 $10.8 Million
Q4 2021 Feb 11, 2022	BUY	$49.91 - $65.56 $264,972 - $348,058	5,309 Added 2.18%	248,534 $15.8 Million
Q3 2021 Nov 16, 2021	BUY	$47.8 - $66.66 $6.65 Million - $9.28 Million	139,149 Added 133.7%	243,225 $14.3 Million
Q2 2021 Aug 16, 2021	BUY	$31.08 - $51.95 $1.29 Million - $2.16 Million	41,628 Added 66.66%	104,076 $5.05 Million
Q1 2021 May 17, 2021	BUY	$35.64 - $85.46 $39,702 - $95,202	1,114 Added 1.82%	62,448 $2.43 Million
Q4 2020 Feb 16, 2021	BUY	$28.07 - $87.83 $1.72 Million - $5.39 Million	61,334 New	61,334 $3.8 Million

Others Institutions Holding KYMR

# of Institutions

181

Shares Held

65.1M

Call Options Held

50.6K

Put Options Held

50.3K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Kymera Therapeutics, Inc. Transaction History